Development of formaldehyde-killed and alum-adjuvanted multicomponent Salmonella Enteritidis phage-type vaccines in chickens
Keywords:
Salmonella Enteritidis (SE); phage types (PTs); chick; killed; alum adjuvantAbstract
Objective: The study objectives were to develop multicomponent formaldehyde-killed and alum-adjuvanted Salmonella Enteritidis (SE) phage-type vaccines in chickens. Materials and Methods: SEPTs 35, 7, 6A, 3A, and 1 were killed, mixed to prepare six combinations, namely, V635, V671, V673, V675, and V613 and administered (0.20 ml) to chicks (n = 124) of 6 groups (CV635, CV671, CV673, CV675, and CV613), and one non-administered group as a control. Other chicks underwent 0.20 ml with SE 6A per chick (1,010 cfu per ml) as a challenge and were labeled CVZC, CV635C, CV671C, CV673C, CV675C, and CV613C. The blood, swab of cloaca, liver, spleen, digesta of the middle part of the intestine, and digesta of the cecum samples were collected for Salmonella detection. The caecum, bursa of Fabricius, liver, spleen, and ileum tissues were collected for histopathological examination. Results: Salmonella was detected (100%) from the digesta of the middle part of the intestine, swabs of the cloaca, digesta of the caecum, and blood, spleen, and liver samples in the CVZC. Salmonella was not detected from the 3 (50%), 2 (33%), and 1 (17%) samples in the CV671C and CV673C, CV613C and CV635C, and CV675C, respectively. Histopathological changes were mild (lesion scoring of 0.4/3.0) and recorded in the group CVZC in the ileum, cecum, and bursa of Fabricius on days 7 and 14 pc, respectively. Conclusions: All combinations of killed SEPTs could protect the chick against SE infection. However, V673 and V671 products are safer and more effective compared to other products.
J. Adv. Vet. Anim. Res., 12(4): 1286–1296, December 2025
Downloads
13
10
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Amanullah Akhtar, Mohd Hair-Bejo, Elawad A Hussein, Siti Khairani Bejo, Zunita Zakaria

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).